RNS Number : 0550P
Quadrise Fuels International PLC
16 June 2022
 

16 June 2022

 

Quadrise Fuels International plc

("Quadrise," "QFI" or the "Company")

 

Issue of Warrants

 

On 13 June 2022, the Company announced that it had signed a new Material Transfer & Cooperation Agreement (the "Agreement") with its client in Morocco

 

As a result, and pursuant to the Morocco Representation Agreement (as amended) between the Company and Younes Maamar (the "Consultant"), the Company has now issued 3 million warrants to subscribe for new ordinary shares in the Company to the Consultant (the "Warrants"). The Warrants are exercisable at any time until 5 March 2023 at a price of 1.797 pence per new ordinary share.  

 

 For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc


Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

+44 (0)20 7031 7321



Nominated Adviser


Cenkos Securities plc


Ben Jeynes

+44 (0)20 7397 8900

Katy Birkin


Broker

Shore Capital Stockbrokers Limited


Toby Gibbs

+44 (0)20 7408 4090

Fiona Conroy


Public & Investor Relations

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230



Notes to Editors

 


Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels in the global power generation, shipping, industrial and refining industries.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEZZGMVRKGGZZM